Furthermore, Transwell assays demonstrated that the invasive ability of FGFR4-knockdown cells was also markedly lower than that of the control group, indicating that FGFR4 knockdown inhibits the invasiveness of colorectal cancer cells (Figure 1D). Here, FGFR4 is linked to colorectal cancer.